Diacylglycerophosphoinositolglycans
|
LMGP15010098
|
- 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
- PIM3(16:0/14:0)
|
|
|
126457466
|
|
1268.653008
|
C57H105O28P
|
Gangliosides
|
LMSP0601CJ05
|
- Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer(d18:1/24:0)
|
|
|
44262440
|
|
1645.965477
|
C79H143N3O32
|
Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series)
|
LMSP0504AE00
|
- Galalpha1-3(Fucalpha1-2)Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer
- type I B antigen
|
GSG1171
|
|
|
|
|
|
Diacylglycerophosphoinositolglycans
|
LMGP15010197
|
- 2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-(9Z,12Z-hexadecadienoyl)-sn-glycero-3-phospho-1'-myo-inositol)
- PIM5(16:0/16:2(9Z,12Z))
|
|
|
126457565
|
|
1616.758658
|
C71H125O38P
|
Galalpha1-3Galbeta1-4Glc- (Isoglobo series)
|
LMSP0506BI04
|
- Fucalpha1-3GlcNAcbeta1-3Galalpha1-3(GalNAcbeta1-4)Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
|
|
44261695
|
|
1659.981127
|
C80H145N3O32
|
Diacylglycerophosphoethanolamine glycans
|
LMGP21010005
|
- Am-PE(16:0/18:2(9Z,12Z))
- N-(1-deoxyfructosyl)-1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphoethanolamine
|
|
|
101027510
|
|
877.568032
|
C45H84NO13P
|
|
LMSL03001065
|
- 2-octadecanoyl-3-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-6-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-alpha,alpha-trehalose
- PAT18(26:1(2E)(2Me,4Me[S],6Me[S])/24:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S]))
|
|
|
52930902
|
|
2254.01574
|
C144H268O16
|
|
LMSL03000812
|
- 2-octadecanoyl-3-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-6-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-alpha,alpha-trehalose
- PAT18(24:1(2E)(2Me,4Me[S],6Me[S])/24:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S]))
|
|
|
52930649
|
|
2169.92184
|
C138H256O16
|
|
LMSL03000325
|
- 2-O-hexadecanoyl-3-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-6-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-alpha,alpha-trehalose
- PAT16(25:1(2E)(2Me,4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S]))
|
|
|
52930162
|
|
2169.92184
|
C138H256O16
|
|
LMSL03000746
|
- 2-octadecanoyl-3-O-(2,4S,6S-trimethyl-2E-docosenoyl)-6-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-2'-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-4'-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-alpha,alpha-trehalose
- PAT18(22:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S])/24:0(2Me[R],3OH[R],4Me[S],6Me[S])/24:0(2Me[R],3OH[R],4Me[S],6Me[S]))
|
|
|
52930583
|
|
2205.94297
|
C138H260O18
|
|
LMSL03000684
|
- 2-octadecanoyl-3-O-(2,4S,6S-trimethyl-2E-docosenoyl)-6-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-alpha,alpha-trehalose
- PAT18(22:1(2E)(2Me,4Me[S],6Me[S])/24:1(2E)(2Me,4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S]))
|
|
|
52930521
|
|
2169.92184
|
C138H256O16
|
|
LMSL03000493
|
- 2-O-hexadecanoyl-3-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-6-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-2'-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-4'-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-alpha,alpha-trehalose
- PAT16(26:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S])/24:0(2Me[R],3OH[R],4Me[S],6Me[S])/24:1(2E)(2Me,4Me[S],6Me[S]))
|
|
|
52930330
|
|
2215.963705
|
C140H262O17
|
Galalpha1-4Galbeta1-4Glc- (Globo series)
|
LMSP0502AJ02
|
- GalNAcalpha1-3(Fucalpha1-2)Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/18:0)
- type IV A antigen(d18:1/18:0)
|
|
|
44260237
|
|
1765.971352
|
C82H147N3O37
|
Gangliosides
|
LMSP0601BA03
|
- GD1e(d18:1/20:0)
- NeuAcalpha2-3Galbeta1-3(NeuAcalpha2-6)GalNAcbeta1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
|
|
44262174
|
|
1865.003381
|
C86H152N4O39
|
Galalpha1-4Galbeta1-4Glc- (Globo series)
|
LMSP0502AF06
|
- Galbeta1-3(GlcNAcbeta1-6)GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/26:0)
|
|
|
44260209
|
|
1732.038642
|
C84H153N3O33
|
|
LMSL03000834
|
- 2-octadecanoyl-3-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-6-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-alpha,alpha-trehalose
- PAT18(24:1(2E)(2Me,4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S]))
|
|
|
52930671
|
|
2211.96879
|
C141H262O16
|
|
LMSL03000612
|
- 2-O-hexadecanoyl-3-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-6-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-hexacosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-alpha,alpha-trehalose
- PAT16(24:0(2Me[R],3OH[R],4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S])/26:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S]))
|
|
|
52930449
|
|
2187.932405
|
C138H258O17
|
Gangliosides
|
LMSP0601FR04
|
- NeuAcalpha2-3Galbeta1-4GlcNAcbeta1-3(Galalpha1-3Galbeta1-4GlcNAcbeta1-6)Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/22:0)
|
|
|
44263079
|
|
2494.256485
|
C111H195N5O56
|
|
LMSL03000052
|
- 2-O-hexadecanoyl-3-O-(2,4S,6S-trimethyl-2E-docosenoyl)-6-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-4'-O-(2,4S,6S-trimethyl-2E-docosenoyl)-alpha,alpha-trehalose
- PAT16(22:1(2E)(2Me,4Me[S],6Me[S])/24:1(2E)(2Me,4Me[S],6Me[S])/24:1(2E)(2Me,4Me[S],6Me[S])/22:1(2E)(2Me,4Me[S],6Me[S]))
|
|
|
52929889
|
|
2085.82794
|
C132H244O16
|
Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glc- (Neolacto series)
|
LMSP0505AD03
|
- Fucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-Cer(d18:1/20:0)
- type II antigen(d18:1/20:0)
|
|
|
44260998
|
|
1428.870453
|
C70H128N2O27
|
Galalpha1-4Galbeta1-4Glc- (Globo series)
|
LMSP0502AE05
|
- Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/24:0)
- SSEA-3 antigen(d18:1/24:0)
|
|
|
44260200
|
|
1500.927968
|
C74H136N2O28
|
Gangliosides
|
LMSP0601DO06
|
- NeuAcalpha2-3Galbeta1-3(Fucalpha1-4)GlcNAcbeta1-3(Galbeta1-4(Fucalpha1-3)GlcNAcbeta1-6)Galbeta1-4Glcbeta-Cer(d18:1/26:0)
- sLea -Lex(d18:1/26:0)
|
|
|
44262665
|
|
2315.249881
|
C107H190N4O49
|
Gangliosides
|
LMSP0601AE03
|
- NeuAcalpha2-8NeuAcalpha2-3Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer(d18:1/20:0)
|
|
|
44261998
|
|
2027.056206
|
C92H162N4O44
|
Gangliosides
|
LMSP0601BX00
|
- GalNAc-GD1a(Neu5Ac/Neu5Gc)
- GalNAcbeta1-4(NeuAcalpha2-3)Galbeta1-3GalNAcbeta1-4(NeuGcalpha2-3)Galbeta1-4Glcbeta-Cer
|
GSG1036
|
|
|
|
|
|
|
LMSL03000956
|
- 2-octadecanoyl-3-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-6-O-(2,4S,6S-trimethyl-2E-pentacosenoyl)-2'-O-(2,4S,6S-trimethyl-2E-tetracosenoyl)-4'-O-(2R,4S,6S-trimethyl-3R-hydroxy-tetracosanoyl)-alpha,alpha-trehalose
- PAT18(25:1(2E)(2Me,4Me[S],6Me[S])/25:1(2E)(2Me,4Me[S],6Me[S])/24:1(2E)(2Me,4Me[S],6Me[S])/24:0(2Me[R],3OH[R],4Me[S],6Me[S]))
|
|
|
52930793
|
|
2215.963705
|
C140H262O17
|